Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;82(5):186-230.
doi: 10.1016/j.jinf.2020.11.019. Epub 2020 Nov 20.

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19

Sebastian Voicu  1 , Benjamin G Chousterman  2 , Philippe Bonnin  3 , Nicolas Deye  4 , Isabelle Malissin  1 , Arthur Le Gall  5 , Romain Barthélémy  5 , Laetitia Sutterlin  6 , Giulia Naim  6 , Aymen Mrad  6 , Adrien Pepin-Lehalleur  6 , Matthieu Le Dorze  5 , Charles de Roquetaillade  5 , Jean-Michel Ekhérian  6 , Etienne Gayat  2 , Georgios Sidéris  7 , Alexandre Mebazaa  2 , Bruno Mégarbane  8
Affiliations

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19

Sebastian Voicu et al. J Infect. 2021 May.
No abstract available

Keywords: Anticoagulation; Bleeding; COVID-19; Deep vein thrombosis; Prophylaxis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no competing interests.

Figures

Fig 1
Fig. 1
Before-after comparison of proximal deep vein thrombosis (DVT) and major bleeding (MB) prevalence in 93 mechanically ventilated COVID-19 patients.
See this image and copyright information in PMC

References

    1. Brendish N.J., Poole S., Naidu V.V., Mansbridge C.T., Norton N., Borca F., et al. Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: a comparison of patients with and without SARS-CoV-2 infection. J Infect. 2020 S0163-4453(20)30638-1. - PMC - PubMed
    1. Zhang L., Feng X., Zhang D., Jiang C., Mei H., Wang J., et al. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020;142:114–128. - PubMed
    1. Voicu S., Delrue M., Chousterman B.G., Stépanian A., Bonnin P., Malissin I., et al. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications. Eur Rev Med Pharmacol Sci. 2020;24:9161–9168. - PubMed
    1. Edler C., Schröder A.S., Aepfelbacher M., Fitzek A., Heinemann A., Heinrich F., et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med. 2020;134:1275–1284. - PMC - PubMed
    1. Susen S., Tacquard C.A., Godon A., Mansour A., Garrigue D., Nguyen P., et al. Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring. Crit Care. 2020;24:364. - PMC - PubMed